EPHA2 and B-cell chronic lymphocytic leukemia: To discriminate between these two possibilities we preincubated the CLL cells from the 30 patients with saturating amounts of recombinant extracellular domains of human EphA2 (EphA2Fc) which results in ephrinA4 reverse signaling modulating integrin affinity [16].